Cervical cancer contributes to approximately 6-29% of all cancers in Indian women. India accounts for one-quarter of cervical cancer globally. 17% of all cancer deaths amongst women in India aged 30-69 are due to cervical cancer. EVA System visualization technology offers the potential for early detection of cervical cancers.
CHENNAI, India, Jan. 17, 2018 — As per a new World Bank/IFC-funded study by MobileODT and Apollo Hospitals, deploying the EVA (Enhanced Visual Assessment) System at primary cervical cancer screenings leads to a higher detection rate of suspected precancerous and cancerous lesions for women in both urban and rural areas, than a Pap smear alone.
The study assessed MobileODT’s EVA System for high-quality and cost-effective cervical cancer screenings across India. 567 women were screened for cervical cancer via colposcopy with the EVA System, as well as a Pap smear at the first screening. Expert gynecologists reviewed cases through the EVA System’s software to confirm the suspicion of precancerous and/or cancerous lesions, and other abnormalities for potential treatment.
The gynecologists shared high scores of feasibility, usability, and patient satisfaction with the EVA System, which proved to be a quick and easy way to evaluate the cervix. All investigators felt it can be extended to peripheral centers with training where Pap smear collection and interpretation is not easily available.
MobileODT’s CEO Ariel Beery said: “We’re excited to see these results, and are grateful for the opportunity to work with Apollo to extend our life-saving technology to the women of India. Few healthcare institutions in the world have the expertise and reach of Apollo, and we’re looking forward to working with Apollo to save more lives in the future.”
Dr. Mallika Samuel, Senior Consultant Gynecologist, Apollo Hospitals, Chennai and Lead Investigator of the study said, “The Indian healthcare landscape presents significant challenges to patient access and affordability. The deployment of the EVA System can facilitate taking cervical screening to the people of India, enabling early screening and treatment thus slowing down incidences of cervical cancer. Further, it maximizes cervical cancer screening programs and reduces the time to follow up with patients, especially in rural and remote areas.”
See our related news post: http://www.mobileodt.com/news/eva-system-deployment-leads-to-higher-cervical-cancer-detection-rates-in-india-study
About MobileODT
MobileODT is creating the next generation of smart medical solutions. Our EVA (Enhanced Visualisation and Assessment) System combines biomedical optics with the power and connectivity of cellular technology. In 2017, MobileODT piloted the EVA System for Cervical Cancer with Apollo Hospitals and is attending the India-Israel Global Innovation Challenge Initiative in Mumbai, January 15-19, 2018.
For further comment, please contact:
Dharshana Kankaria
dharshanakankaria@mobileodt.com
About Apollo Hospitals
Apollo Hospitals is also the world’s largest private cancer care provider and runs the world’s leading solid organ transplant program. It is acclaimed for pioneering the private healthcare revolution in the country. Each year, Apollo Hospitals reaches a quarter billion patients in India, providing lifesaving care.
For further comment, please contact:
Kusum Sahijpal
Kusum_s@apollohospitals.com
